Related Experiment Video
Updated: Apr 11, 2026

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
CD4+CD29+T cells are blamed for the persistent inflammatory response in ulcerative colitis
Yuzhen Zhu1, Yanling Feng2, Hongbo Liu3
1Guangdong Key Laboratory for Research and Development of Natural Drug, Research Institute of Traditional Chinese Medicine, Guangdong Medical College Zhanjiang City, Guangdong, China.
CD4+CD29+T cells and MPO/VCAM-1 are upregulated in ulcerative colitis (UC) patients and a rat model. These markers correlate with disease severity, suggesting their role in UC inflammation.
Area of Science:
- Immunology
- Gastroenterology
- Oncology
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease linked to colorectal cancer.
- Accurate diagnosis and understanding of UC pathogenesis are crucial.
Purpose of the Study:
- To investigate the expression trends of CD4+CD29+T cells, MPO, and VCAM-1 in a rat UC model and human UC patients.
- To evaluate the correlation between CD4+CD29+T cells and UC disease severity.
Main Methods:
- A rat model of UC was induced using DNCB liquid and acetate solution.
- Expression levels of CD4+CD29+T cells, MPO, and VCAM-1 were measured in rat and human samples.
- Pearson correlation analysis was used to assess the relationship with disease severity scores (DAI).
Main Results:
- Upregulated expression of CD4+CD29+T cells, MPO, and VCAM-1 was observed in both rat UC models and human UC patients.
- Expression levels were highest in rats at two weeks post-induction and in active UC patients.
- CD4+CD29+T cells in peripheral blood positively correlated with disease activity scores in both rats and humans.
Conclusions:
- CD4+CD29+T cells are identified as key effector cells in the persistent inflammation of UC.
- VCAM-1 and CD29 may play a role in inducing the infiltration of these cells into the inflamed colon.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

